Concepedia

Hartmut Schirok

HS

Statistics

Publications

25

Citations

1.3K

H-Index

18

Active since

1997

Affiliations

Bayer (Germany)(Current)

University of Göttingen

Universität Hamburg

Santhera Pharmaceuticals (Switzerland)

University Medical Center Hamburg-Eppendorf

Hartmut Schirok is an author at Bayer (Germany) specializing in medicinal chemistry, chemistry, and organic chemistry.

Publications per year

1997–2022

25

Publications

25

Discovery of the Soluble Guanylate Cyclase Stimulator Vericiguat (BAY 1021189) for the Treatment of Chronic Heart Failure

Markus Follmann, Jens Ackerstaff, Gorden Redlich et al. · Journal of Medicinal Chemistry · 2017 · 197 citations · Full text

, , +17

Discovery of Riociguat (BAY 63‐2521): A Potent, Oral Stimulator of Soluble Guanylate Cyclase for the Treatment of Pulmonary Hypertension

Joachim Mittendorf, Stefan Weigand, Cristina Alonso‐Alija et al. · ChemMedChem · 2009 · 182 citations

, , +16

Enantioselective Highly Efficient Synthesis of (−)-Cephalotaxine Using Two Palladium-Catalyzed Transformations

Lutz F. Tietze, Hartmut Schirok · Journal of the American Chemical Society · 1999 · 102 citations

, , +11

Paired electrolysis-enabled nickel-catalyzed enantioselective reductive cross-coupling between α-chloroesters and aryl bromides

Dong Liu, Zhao‐Ran Liu, Zhenhua Wang et al. · Nature Communications · 2022 · 94 citations · Full text

, , +17

Cardiovascular effects of a novel potent and highly selective azaindole‐based inhibitor of Rho‐kinase

R. Kast, Hartmut Schirok, Santiago Figueroa‐Pérez et al. · British Journal of Pharmacology · 2007 · 65 citations · Full text

, , +14

1–5 of 25